Medicines (Cyanogenetic Substances) Order 1984
| Jurisdiction | UK Non-devolved |
| Citation | SI 1984/187 |
1984 No. 187
MEDICINES
The Medicines (Cyanogenetic Substances) Order 1984
Made 20th February 1984
Coming into Operation 1st March 1984
The Secretaries of State respectively concerned with health in England, in Wales and in Scotland and the Department of Health and Social Services for Northern Ireland, acting jointly, in exercise of powers conferred by section 104(1) of the Medicines Act 1968 and now vested in them1and of all other powers enabling them in that behalf, after consulting pursuant to section 129(6) of that Act such organisations as appear to them to be representative of interests likely to be substantially affected by the order and after taking into account pursuant to section 129(7) of that Act the advice of the Committee on Safety of Medicines, hereby make the following order, a draft of which has been laid before Parliament pursuant to section 104(2) of that Act and has been approved by resolution of each House of Parliament:
Citation, commencement and interpretation
1.—(1) This order may be cited as the Medicines (Cyanogenetic Substances) Order 1984 and shall come into operation on the tenth day after the day on which it is made.
(2) In this order—
“” means
“” means preparations which—
(a) are presented for sale or supply under the name of, or as containing, amygdalin, laetrile or vitamin B17 or
(b) contain more than 0.1 per cent by weight of any substance having the formula either α-Cyanobenzyl-6-O-Β-D-glucopyranosyl-Β-D-glucopyranoside or α-Cyanobenzyl-Β-D-glucopyranosiduronic acid.
Application of specified provisions of the Act
2. For the purposes of section 104(1) of the Act, cyanogenetic substances which are intended for human consumption and are not manufactured, sold, supplied, imported or exported wholly or mainly in either of the ways specified in section 130(1) of the Act are hereby specified as substances which appear to the Health Ministers to be substances which are not medicinal products but which are manufactured, sold, supplied, imported or exported for use wholly or partly for a medicinal purpose and it is hereby directed that the provisions contained in Part I, sections 51, 52, 55(1), 57, 58, 61 to 67, 85 to 88, 91 to 93, 95 and 97 and Part VIII of the Act shall have effect in relation to such substances as those provisions have effect in relation to medicinal products.
John Patten
...
To continue reading
Request your trial